Michela Deleidi Selected Research

Inflammation (Inflammations)

2/2012

Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michela Deleidi Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 10/2023 - 11/2010
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 07/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2012
3	Gaucher Disease (Gaucher's Disease) 01/2023 - 06/2014
2	Brain Diseases (Brain Disorder) 01/2023 - 10/2008
2	Neuroinflammatory Diseases 02/2012 - 12/2010
1	COVID-19 02/2024
1	Synucleinopathies 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2023
1	Cerebellar Ataxia (Dysmetria) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Cognitive Dysfunction 10/2021
1	Infections 10/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2017
1	Proteostasis Deficiencies 01/2017
1	Atrophy 03/2015
1	Neuroblastoma 01/2013
1	Inflammation (Inflammations) 02/2012
1	Neoplasms (Cancer) 07/2011
1	Encephalitis (Encephalitis, Rasmussen) 12/2010
1	Nerve Degeneration 12/2010

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 10/2023 - 07/2012
4	Glucosylceramidase (Glucocerebrosidase)IBA 01/2023 - 06/2014
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2012
2	SynucleinsIBA 01/2023 - 01/2017
2	EnzymesIBA 01/2023 - 01/2023
1	Janus KinasesIBA 02/2024
1	ruxolitinibIBA 02/2024
1	AntioxidantsIBA 10/2023
1	NAD (NADH)IBA 01/2023
1	Acid CeramidaseIBA 01/2023
1	GlycolipidsIBA 01/2023
1	pitrilysinIBA 10/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	Metalloproteases (Metalloproteinases)IBA 10/2021
1	Protein AggregatesIBA 10/2021
1	Complement Factor H (Factor H)IBA 01/2020
1	nicotinamide-beta-ribosideIBA 01/2018
1	alpha-SynucleinIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	PTEN-induced putative kinaseIBA 11/2016
1	AcidsIBA 06/2014
1	CalciumIBA 06/2014
1	NestinIBA 01/2013
1	UbiquinoneIBA 07/2012
1	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 07/2012
1	Sirolimus (Rapamycin)FDA Link 07/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2012
1	CateninsIBA 02/2012
1	Toll-Like Receptor 3IBA 12/2010
1	Poly I-CIBA 12/2010
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2010

Therapy/Procedure

6	Therapeutics 01/2023 - 10/2008
3	Transplantation 03/2015 - 01/2011
1	Autologous Transplantation 03/2015
1	Stem Cell Transplantation 07/2011